We are live on ! Find out more
RPRX

Repros Therapeutics Inc.
RPRX

Delisted

RPRX was delisted on the 31st of January, 2018.

Back to rankings

81 hedge funds and large institutions have $414M invested in Repros Therapeutics Inc. in 2013 Q2 according to their latest regulatory filings, with 81 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

23% less call options, than puts

Call options by funds: $35.1M | Put options by funds: $45.3M

Holders
81
Holders Change
+81
Holders Change %
–
% of All Funds
2.64%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.07%
New
81
Increased
–
Reduced
–
Closed
–
Calls
$35.1M
Puts
$45.3M
Net Calls
-$10.2M
Net Calls Change
-$10.2M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Goldman Sachs
26
Goldman Sachs
New York
$4.2M +$4.02M +227,613 New
JP Morgan Chase
27
JP Morgan Chase
New York
$3.71M +$3.55M +200,805 New
PA
28
Perceptive Advisors
New York
$3.35M +$3.2M +181,430 New
HCMT
29
Highland Capital Management (Texas)
Texas
$3.05M +$2.92M +165,074 New
Balyasny Asset Management
30
Balyasny Asset Management
Illinois
$2.88M +$2.75M +155,851 New
GACM
31
Green Arrow Capital Management
New York
$2.31M +$2.21M +125,275 New
CII
32
CR Intrinsic Investors
Connecticut
$2.31M +$2.21M +125,000 New
Bank of America
33
Bank of America
North Carolina
$2.09M +$2M +113,509 New
Bank of New York Mellon
34
Bank of New York Mellon
New York
$1.85M +$1.77M +100,204 New
JGC
35
J. Goldman & Co
New York
$1.75M +$1.68M +94,875 New
Deutsche Bank
36
Deutsche Bank
Germany
$1.74M +$1.67M +94,399 New
AC
37
Ascend Capital
California
$1.62M +$1.55M +87,711 New
Geode Capital Management
38
Geode Capital Management
Massachusetts
$1.42M +$1.36M +76,925 New
TCIM
39
TIAA CREF Investment Management
New York
$1.4M +$1.34M +76,076 New
SM
40
Sabby Management
Florida
$1.15M +$1.1M +62,090 New
Wellington Management Group
41
Wellington Management Group
Massachusetts
$927K +$888K +50,268 New
BIM
42
BlackRock Investment Management
Delaware
$921K +$882K +49,941 New
Nomura Holdings
43
Nomura Holdings
Japan
$858K +$821K +46,498 New
California Public Employees Retirement System
44
California Public Employees Retirement System
California
$843K +$807K +45,689 New
PIM
45
Partner Investment Management
California
$828K +$793K +44,900 New
Citigroup
46
Citigroup
New York
$757K +$724K +41,019 New
California State Teachers Retirement System (CalSTRS)
47
California State Teachers Retirement System (CalSTRS)
California
$599K +$574K +32,489 New
CS
48
Credit Suisse
Switzerland
$544K +$521K +29,473 New
Dimensional Fund Advisors
49
Dimensional Fund Advisors
Texas
$526K +$504K +28,532 New
Charles Schwab
50
Charles Schwab
California
$511K +$472K +26,700 New
1
2
3 4

RPRX Hedge Fund Activity: Q2 2013 in Review

81 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Repros Therapeutics Inc. (RPRX) for Q2 2013, worth a combined $414M.

Buyers outnumbered sellers: 81 funds opened new RPRX positions and 0 closed out — a net gain of 81 holders — while 0 added to existing stakes and 0 trimmed.

  • 81 institutional investors held Repros Therapeutics Inc. (RPRX) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $414M of Repros Therapeutics Inc. stock for Q2 2013.
  • 81 funds opened new Repros Therapeutics Inc. positions in Q2 2013 and 0 closed out, a net change of +81 holders.

Based on aggregated 13F filings for Q2 2013.